Axial3D Company Profile

Background

Mission and Vision

Axial3D is dedicated to making patient-specific care routine by providing surgeons, radiologists, and engineers with innovative 3D solutions. The company's mission is to transform DICOM images into detailed, actionable 3D data using patented machine learning and AI technology, thereby enhancing surgical excellence and improving patient outcomes.

Primary Area of Focus

Specializing in the creation of patient-specific 3D printed anatomical models, Axial3D converts medical imaging data from CT and MRI scans into precise physical replicas. These models are instrumental in pre-operative planning, surgical simulation, and patient education, offering a tactile understanding of complex anatomies that surpasses traditional 2D imaging.

Industry Significance

By integrating advanced technologies such as AI and machine learning into the medical imaging and 3D printing process, Axial3D addresses critical challenges in healthcare. The company's solutions reduce the time and expertise required for image segmentation, making personalized surgical planning more accessible and efficient. This innovation positions Axial3D as a leader in the medical 3D printing industry, contributing significantly to the advancement of personalized healthcare.

Key Strategic Focus

Core Objectives

Automation of Image Segmentation: Utilizing AI to streamline the conversion of 2D medical images into 3D models, significantly reducing processing time.

Global Expansion: Extending services to international markets, particularly focusing on the United States and Europe.

Scalability: Developing solutions that enable healthcare institutions to adopt 3D printing without substantial capital investment or specialized personnel.

Areas of Specialization

Surgical Planning: Providing models that assist surgeons in pre-operative planning and simulation.

Medical Education: Enhancing training and education through accurate anatomical replicas.

Patient Communication: Improving patient understanding and consent processes with tangible models.

Key Technologies Utilized

Machine Learning Algorithms: Automating the segmentation of medical images.

Cloud-Based Platforms: Facilitating easy access and scalability of 3D printing services.

3D Printing Technologies: Producing high-fidelity anatomical models.

Primary Markets Targeted

Hospitals and Healthcare Institutions: Implementing 3D printing solutions for surgical planning and patient care.

Medical Device Manufacturers: Collaborating to create patient-specific devices and implants.

Educational Institutions: Providing models for medical training and education.

Financials and Funding

Funding History

July 2019: Closed a $3 million funding round led by Imprimatur Capital Fund Management, with participation from Techstart Ventures, Clarendon Fund Managers, and Innovation Ulster Ltd.

November 2022: Secured a $15 million investment round, including a $10 million strategic investment from Stratasys Ltd.

April 2025: Raised $18.2 million to scale AI-powered 3D medical imaging technology, with 57 Stars becoming the largest shareholder through a $10 million investment.

Intended Utilization of Capital

Technology Development: Enhancing AI and machine learning capabilities for image segmentation.

Market Expansion: Establishing a presence in the U.S. and other international markets.

Team Growth: Increasing headcount, particularly in machine learning and production teams.

Technological Platform and Innovation

Proprietary Technologies

AI-Powered Segmentation Platform: Automates the conversion of 2D medical images into 3D printable files, reducing processing time from hours to minutes.

Significant Scientific Methods

Machine Learning Algorithms: Employed to enhance the accuracy and efficiency of image segmentation.

Cloud Computing: Utilized for scalable processing and storage of medical imaging data.

Leadership Team

Roger Johnston: Chief Executive Officer

Daniel Crawford: Founder and Chief Scientific Officer

Rory Hanratty: Chief Technology Officer

Nigel Hutchinson: Chief Operating Officer

Cathy Coomber: Head of Production

Abbey Delaney: Senior Director of Marketing

Joanne Flatley: Head of Quality Assurance and Regulatory Affairs

Helen McGhee: Product Lead

Key Contributions

Roger Johnston: Oversees company strategy and operations, driving growth and innovation.

Daniel Crawford: Leads scientific research and development, focusing on AI and machine learning applications.

Rory Hanratty: Manages technological infrastructure and development.

Nigel Hutchinson: Oversees operational processes and efficiency.

Competitor Profile

Market Insights and Dynamics

The global 3D printing medical devices market is experiencing significant growth, driven by increasing adoption of personalized healthcare solutions and advancements in 3D printing technologies. The market is projected to see a compounding annual growth rate of 23% in 2019.

Competitor Analysis

Materialise NV: Offers medical 3D printing software and services, focusing on patient-specific solutions.

3D Systems Corporation: Provides a range of 3D printing solutions, including healthcare applications.

Stratasys Ltd.: A leader in polymer 3D printing solutions, with a strategic investment in Axial3D to enhance patient-specific 3D printing adoption.

Strategic Collaborations and Partnerships

Stratasys Ltd.: In November 2022, Stratasys made a $10 million strategic investment in Axial3D, aiming to make patient-specific 3D printing solutions more accessible to hospitals and medical device manufacturers.

Amazon Web Services (AWS): Utilized AWS's cloud infrastructure and machine learning services to enhance the scalability and efficiency of their 3D printing solutions.

Operational Insights

Strategic Considerations

Scalability: Leveraging cloud-based platforms and AI to handle increasing demand without proportional increases in resources.

Market Position: Differentiating through proprietary AI technologies that streamline the 3D printing process.

Competitive Advantages: Offering rapid turnaround times and high-quality models, reducing the burden on healthcare providers.

Strategic Opportunities and Future Directions

Strategic Roadmap

Technology Enhancement: Continued development of AI algorithms to further automate and improve the accuracy of image segmentation.

Market Expansion: Strengthening presence in existing markets and exploring new international opportunities.

Product Diversification: Expanding offerings to include a broader range of medical specialties and applications.

Opportunities for Expansion

Telemedicine Integration: Collaborating with telemedicine providers to offer remote surgical planning solutions.

Regulatory Approvals: Pursuing additional certifications to expand into new markets and applications.

Current Strengths Positioning for Future Objectives

Proprietary Technology: The AI-powered segmentation platform provides a competitive edge in efficiency and scalability.

Strategic Partnerships: Collaborations with industry leaders like Stratasys and AWS enhance credibility and resource access.

Experienced Leadership: A seasoned executive team with expertise in technology, healthcare, and business development.

Contact Information

Website: Axial3D Official Website

LinkedIn: Axial3D LinkedIn Profile

Twitter: Axial3D Twitter Profile

Facebook: Axial3D Facebook Page

Instagram: Axial3D Instagram Profile

axial3d